Weekly Bond Bulletin
A shot in the arm for EMFX
With positive vaccine developments presenting an eventual pathway out of Covid-19 restrictions, fixed income investors may find value in emerging market currencies (EMFX).
Recent vaccine developments have boosted markets and allowed investors a glimpse of a post-pandemic society. Despite near-term concerns around rising case counts in some countries, risk sentiment should be robust over the medium to longer term, with spread products benefiting. Success on other vaccines could be particularly supportive for emerging markets: the AstraZeneca vaccine is expected to be distributed more widely across the globe, with many more pre-orders taken from emerging market (EM) countries than has been the case with other vaccines. If the AstraZeneca vaccine is effective, emerging markets stand to benefit, since they have hitherto been more vulnerable from a public health standpoint, and certain EM economies (such as Thailand, Peru and South Africa) are sensitive to travel and tourism activity. Stronger global growth should also lead to a pick-up in global trade and be supportive for commodity prices. The other key fundamental support for emerging markets is central bank policy, which is keeping core rates anchored, and EM central banks remain consistent with their developed market counterparts in their easy policy stance.
One potential valuation opportunity within the emerging market complex is EMFX, which looks very cheap relative to the performance of other sectors since March. Equities, developed market credit and hard currency emerging market debt are all back in positive territory. Emerging market local currency bonds are down 0.77% on a total return basis, but the carry and price return on the bonds has been strong at 6.83%: the FX component, down 7.16%, has entirely driven the overall negative return. Selectivity is crucial given the differentiation in the index, but EMFX could present an opportunity, especially given the yield enhancement on offer relative to developed markets.
EM currencies have substantially lagged the risk recovery
Source: Bloomberg; data as of 18 November 2020. IG=investment grade.
Almost USD 750 million has flowed into EM local currency funds so far in November. We have also recently observed, through investor surveys, a significant shift upwards in EMFX positioning across both emerging market debt and equity, suggesting robust demand for the asset class more broadly. As a note of caution, it’s important to watch for signs that EMFX isn’t becoming overbought, but nevertheless, key supportive technical factors persist. The global grab for yield has not gone away, with a huge amount of assets still sitting in money market funds (currently standing at USD 4.3 trillion, compared to USD 3.6 trillion at the start of 2020). In addition, we believe there could be crossover investors—such as those managing unconstrained and multi-asset strategies—with more room to add to their EM allocations.
What does this mean for fixed income investors?
As progress is made towards multiple vaccines, lifting hopes that travel and tourism can return to become a feature of normal life, EM economies should benefit. For investors on the lookout for pockets of value, EMFX could present an area to focus their search. With current demand dynamics fairly strong, and an ever-present technical tailwind from the global hunt for yield, 2020’s laggard could look interesting going into 2021.
About the Bond Bulletin
Each week J.P. Morgan Asset Management’s Global Fixed Income, Currency and Commodities group reviews key issues for bond investors through the lens of its common Fundamental, Quantitative Valuation and Technical (FQT) research framework.Click here to read more about our FQT capabilities
NOT FOR RETAIL DISTRIBUTION: This communication has been prepared exclusively for institutional, wholesale, professional clients and qualified investors only, as defined by local laws and regulations.
The views contained herein are not to be taken as advice or a recommendation to buy or sell any investment in any jurisdiction, nor is it a commitment from J.P. Morgan Asset Management or any of its subsidiaries to participate in any of the transactions mentioned herein. Any forecasts, figures, opinions or investment techniques and strategies set out are for information purposes only, based on certain assumptions and current market conditions and are subject to change without prior notice. All information presented herein is considered to be accurate at the time of production. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine, together with their own financial professional, if any investment mentioned herein is believed to be appropriate to their personal goals. Investors should ensure that they obtain all available relevant information before making any investment. It should be noted that investment involves risks, the value of investments and the income from them may fluctuate in accordance with market conditions and taxation agreements and investors may not get back the full amount invested. Both past performance and yields are not reliable indicators of current and future results.
J.P. Morgan Asset Management is the brand for the asset management business of JPMorgan Chase & Co. and its affiliates worldwide.
To the extent permitted by applicable law, we may record telephone calls and monitor electronic communications to comply with our legal and regulatory obligations and internal policies. Personal data will be collected, stored and processed by J.P. Morgan Asset Management in accordance with our privacy policies at https://am.jpmorgan.com/global/privacy.
This communication is issued by the following entities:
In the United States, by J.P. Morgan Investment Management Inc. or J.P. Morgan Alternative Asset Management, Inc., both regulated by the Securities and Exchange Commission; in Latin America, for intended recipients’ use only, by local J.P. Morgan entities, as the case may be. In Canada, for institutional clients’ use only, by JPMorgan Asset Management (Canada) Inc., which is a registered Portfolio Manager and Exempt Market Dealer in all Canadian provinces and territories except the Yukon and is also registered as an Investment Fund Manager in British Columbia, Ontario, Quebec and Newfoundland and Labrador. In the United Kingdom, by JPMorgan Asset Management (UK) Limited, which is authorized and regulated by the Financial Conduct Authority; in other European jurisdictions, by JPMorgan Asset Management (Europe) S.à r.l. In Asia Pacific (“APAC”), by the following issuing entities and in the respective jurisdictions in which they are primarily regulated: JPMorgan Asset Management (Asia Pacific) Limited, or JPMorgan Funds (Asia) Limited, or JPMorgan Asset Management Real Assets (Asia) Limited, each of which is regulated by the Securities and Futures Commission of Hong Kong; JPMorgan Asset Management (Singapore) Limited (Co. Reg. No. 197601586K), this advertisement or publication has not been reviewed by the Monetary Authority of Singapore; JPMorgan Asset Management (Taiwan) Limited; JPMorgan Asset Management (Japan) Limited, which is a member of the Investment Trusts Association, Japan, the Japan Investment Advisers Association, Type II Financial Instruments Firms Association and the Japan Securities Dealers Association and is regulated by the Financial Services Agency (registration number “Kanto Local Finance Bureau (Financial Instruments Firm) No. 330”); in Australia, to wholesale clients only as defined in section 761A and 761G of the Corporations Act 2001 (Commonwealth), by JPMorgan Asset Management (Australia) Limited (ABN 55143832080) (AFSL 376919).
For U.S. only: If you are a person with a disability and need additional support in viewing the material, please call us at 1-800-343-1113 for assistance.
Copyright 2020 JPMorgan Chase & Co. All rights reserved.